BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 23635628)

  • 21. Cyclical progestogens for heavy menstrual bleeding.
    Lethaby A; Irvine G; Cameron I
    Cochrane Database Syst Rev; 2000; (2):CD001016. PubMed ID: 10796587
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antifibrinolytics for heavy menstrual bleeding.
    Cooke I; Lethaby A; Farquhar C
    Cochrane Database Syst Rev; 2000; (2):CD000249. PubMed ID: 10796518
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endometrial ablation or resection versus levonorgestrel intra-uterine system for the treatment of women with heavy menstrual bleeding and a normal uterine cavity: a systematic review with meta-analysis.
    Bergeron C; Laberge PY; Boutin A; Thériault MA; Valcourt F; Lemyre M; Maheux-Lacroix S
    Hum Reprod Update; 2020 Feb; 26(2):302-311. PubMed ID: 31990359
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A randomized trial comparing the 52-mg levonorgestrel system with combination oral contraceptives for treatment of heavy menstrual bleeding.
    Matteson KA; Valcin J; Raker CA; Clark MA
    Am J Obstet Gynecol; 2023 Nov; 229(5):532.e1-532.e13. PubMed ID: 37536486
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pre-operative endometrial thinning agents before endometrial destruction for heavy menstrual bleeding.
    Tan YH; Lethaby A
    Cochrane Database Syst Rev; 2013 Nov; (11):CD010241. PubMed ID: 24234875
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost-effectiveness of treatments for heavy menstrual bleeding.
    Spencer JC; Louie M; Moulder JK; Ellis V; Schiff LD; Toubia T; Siedhoff MT; Wheeler SB
    Am J Obstet Gynecol; 2017 Nov; 217(5):574.e1-574.e9. PubMed ID: 28754438
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A 52-mg levonorgestrel-releasing intrauterine system vs bipolar radiofrequency nonresectoscopic endometrial ablation in women with heavy menstrual bleeding: long-term follow-up of a multicenter randomized controlled trial.
    Huijs DPC; Derickx AJM; Beelen P; Leemans JC; van Kuijk SMJ; Bongers MY; Geomini PMAJ
    Am J Obstet Gynecol; 2024 May; 230(5):542.e1-542.e10. PubMed ID: 38280433
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen.
    Dominick S; Hickey M; Chin J; Su HI
    Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD007245. PubMed ID: 26649916
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A randomised controlled trial of the clinical effectiveness and cost-effectiveness of the levonorgestrel-releasing intrauterine system in primary care against standard treatment for menorrhagia: the ECLIPSE trial.
    Gupta JK; Daniels JP; Middleton LJ; Pattison HM; Prileszky G; Roberts TE; Sanghera S; Barton P; Gray R; Kai J;
    Health Technol Assess; 2015 Oct; 19(88):i-xxv, 1-118. PubMed ID: 26507206
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Danazol for heavy menstrual bleeding.
    Beaumont H; Augood C; Duckitt K; Lethaby A
    Cochrane Database Syst Rev; 2007 Jul; 2007(3):CD001017. PubMed ID: 17636649
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Levonorgestrel-releasing intrauterine system versus conventional medical therapy for heavy menstrual bleeding in the Asia-Pacific region.
    Lee BS; Ling X; Asif S; Kraemer P; Hanisch JU; Inki P
    Int J Gynaecol Obstet; 2013 Apr; 121(1):24-30. PubMed ID: 23340271
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Levonorgestrel intrauterine system versus medical therapy for menorrhagia.
    Gupta J; Kai J; Middleton L; Pattison H; Gray R; Daniels J;
    N Engl J Med; 2013 Jan; 368(2):128-37. PubMed ID: 23301731
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Medical management of heavy menstrual bleeding: a comprehensive review of the literature.
    Bitzer J; Heikinheimo O; Nelson AL; Calaf-Alsina J; Fraser IS
    Obstet Gynecol Surv; 2015 Feb; 70(2):115-30. PubMed ID: 25671373
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Danazol for heavy menstrual bleeding.
    Beaumont H; Augood C; Duckitt K; Lethaby A
    Cochrane Database Syst Rev; 2002; (2):CD001017. PubMed ID: 12076401
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Non-surgical interventions for treating heavy menstrual bleeding (menorrhagia) in women with bleeding disorders.
    Ray S; Ray A
    Cochrane Database Syst Rev; 2016 Nov; 11(11):CD010338. PubMed ID: 27841443
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Non-surgical interventions for treating heavy menstrual bleeding (menorrhagia) in women with bleeding disorders.
    Ray S; Ray A
    Cochrane Database Syst Rev; 2014 Nov; (11):CD010338. PubMed ID: 25426776
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Decline in Danish use of oral tranexamic acid with increasing use of the levonorgestrel-releasing intrauterine system: a nationwide drug utilization study.
    Meaidi A; Kuhr Skals R; Alexander Gerds T; Lidegaard O; Torp-Pedersen C
    Contraception; 2020 May; 101(5):321-326. PubMed ID: 31935386
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Randomised comparative trial of the levonorgestrel intrauterine system and norethisterone for treatment of idiopathic menorrhagia.
    Irvine GA; Campbell-Brown MB; Lumsden MA; Heikkilä A; Walker JJ; Cameron IT
    Br J Obstet Gynaecol; 1998 Jun; 105(6):592-8. PubMed ID: 9647148
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The current status of hormonal therapies for heavy menstrual bleeding.
    Heikinheimo O; Fraser I
    Best Pract Res Clin Obstet Gynaecol; 2017 Apr; 40():111-120. PubMed ID: 28238590
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Management of initial bleeding or spotting after levonorgestrel-releasing intrauterine system placement: a randomized controlled trial.
    Sørdal T; Inki P; Draeby J; O'Flynn M; Schmelter T
    Obstet Gynecol; 2013 May; 121(5):934-941. PubMed ID: 23635728
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.